Newsroom

Law360 reports that dozens of federal court lawsuits alleging that Bristol-Myers Squibb didn’t provide adequate warning to American users about the risk of compulsive gambling associated with the top-selling prescription antipsychotic drug Abilify.  Attorneys have asked the U.S. Judicial Panel on Multidistrict Litigation to consolidate the cases in Florida.